{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:58Z","timestamp":1791482278628,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.canep.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T14:30:14Z","timestamp":1460817014000},"page":"186-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004\u201315"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-3704","authenticated-orcid":false,"given":"Eve","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-8444","authenticated-orcid":false,"given":"Simon","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Patmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2016.03.011_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"July (5)","key":"10.1016\/j.canep.2016.03.011_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canep.2016.03.011_bib0015","series-title":"James Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.canep.2016.03.011_bib0020","series-title":"International Statistical Classification of Diseases and Related Health Problems ICD-10 Version:2015 [Internet]. ICD-10 Version:2015","author":"World Health Organization","year":"2015"},{"issue":"26","key":"10.1016\/j.canep.2016.03.011_bib0025","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canep.2016.03.011_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.leukres.2014.11.025","article-title":"The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands","volume":"39","author":"Dinmohamed","year":"2015","journal-title":"Leuk. Res."},{"issue":"June","key":"10.1016\/j.canep.2016.03.011_bib0035","article-title":"Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes","author":"McQuilten","year":"2015","journal-title":"Cancer"},{"issue":"April (6)","key":"10.1016\/j.canep.2016.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer (Oxford, Eng.: 1990)."},{"key":"10.1016\/j.canep.2016.03.011_bib0045","unstructured":"NCIN. Cancer by Deprivation in England: incidence 1996\u20132010 mortality 1997\u20132011: a report from the National Cancer Intelligence Network [Internet]. 2014 [cited 2011 Feb 16]. Available from: http:\/\/www.ncin.org.uk\/about_ncin\/cancer_by_deprivation_in_england."},{"issue":"March (9972)","key":"10.1016\/j.canep.2016.03.011_bib0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25\u2008676\u2008887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"June (6)","key":"10.1016\/j.canep.2016.03.011_bib0055","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","article-title":"Annual report to the nation on the status of cancer, 1975\u20132011, featuring incidence of Breast cancer subtypes by Race\/Ethnicity, poverty, and state","volume":"107","author":"Kohler","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"April (16)","key":"10.1016\/j.canep.2016.03.011_bib0060","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2008-09-179341","article-title":"Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005","volume":"113","author":"Derolf","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canep.2016.03.011_bib0065","unstructured":"HAEMACARE Working Group. Manual for coding and reporting haematological malignancies. Tumori. 2010 Aug;96(4):i\u2013A32."},{"issue":"June (9)","key":"10.1016\/j.canep.2016.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejca.2014.02.008","article-title":"Towards optimal clinical and epidemiological registration of haematological malignancies: guidelines for recording progressions, transformations and multiple diagnoses","volume":"51","author":"Gavin","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2016.03.011_bib0075","series-title":"Hematopoietic and Lymphoid Neoplasm Coding Manual","first-page":"20850","author":"Ruhl","year":"2015"},{"issue":"March (3)","key":"10.1016\/j.canep.2016.03.011_bib0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1055-9965.EPI-11-1087","article-title":"Underreporting of myeloid malignancies by United States cancer registries","volume":"21","author":"Craig","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canep.2016.03.011_bib0085","unstructured":"Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review, 1975\u20132012, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2012\/based on November 2014 SEER data submission, posted to the SEER web site, April 2015 [Internet]. 2014. Available from: http:\/\/seer.cancer.gov\/csr\/1975_2012\/."},{"issue":"2","key":"10.1016\/j.canep.2016.03.011_bib0090","first-page":"77","article-title":"Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries","volume":"41","author":"Polednak","year":"2014","journal-title":"J. Registry Manag."},{"issue":"November (19)","key":"10.1016\/j.canep.2016.03.011_bib0095","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"issue":"August (8)","key":"10.1016\/j.canep.2016.03.011_bib0100","article-title":"Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain","volume":"98","author":"Osca-Gelis","year":"2013","journal-title":"Haematologica"},{"issue":"March (5)","key":"10.1016\/j.canep.2016.03.011_bib0105","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ejca.2013.12.002","article-title":"Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010","volume":"50","author":"Dinmohamed","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2016.03.011_bib0110","unstructured":"Public Health England. National Cancer Intelligence Network: Trends in incidence and outcome for haematological cancers in England: 2001\u20132010 [Internet]. 2014 Nov. Report No.: 2014464. Available from: file:\/\/\/C:\/Users\/eve.roman\/Downloads\/Haem_Report_FINAL_PHE_CT_edit_final_.pdf."},{"issue":"June (6)","key":"10.1016\/j.canep.2016.03.011_bib0115","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/leu.2015.73","article-title":"The EUTOS population-based registry: incidence and clinical characteristics of 2904CML patients in 20 European Countries","volume":"29","author":"Hoffmann","year":"2015","journal-title":"Leukemia"},{"issue":"July (7)","key":"10.1016\/j.canep.2016.03.011_bib0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.leukres.2015.04.001","article-title":"Change of prognosis of patients with myelodysplastic syndromes during the last 30 years","volume":"39","author":"Neukirchen","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canep.2016.03.011_bib0125","series-title":"Cancer in Australia: an Overview, 2010","author":"Australian Institute of Health and Welfare","year":"2010"},{"issue":"6","key":"10.1016\/j.canep.2016.03.011_bib0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2188\/jea.JE20140042","article-title":"Incidence of myelodysplastic syndrome in Japan","volume":"24","author":"Chihara","year":"2014","journal-title":"J. Epidemiol."},{"issue":"June (11)","key":"10.1016\/j.canep.2016.03.011_bib0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cncr.28641","article-title":"Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study","volume":"120","author":"McQuilten","year":"2014","journal-title":"Cancer"},{"issue":"March (5)","key":"10.1016\/j.canep.2016.03.011_bib0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","article-title":"The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research","volume":"148","author":"Smith","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"November (11)","key":"10.1016\/j.canep.2016.03.011_bib0145","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2016.03.011_bib0150","series-title":"Cancer Reform Strategy","author":"Department of Health","year":"2007"},{"key":"10.1016\/j.canep.2016.03.011_bib0155","series-title":"Improving Outcomes: A Strategy for Cancer [Internet]","author":"Department of Health","year":"2011"},{"key":"10.1016\/j.canep.2016.03.011_bib0160","series-title":"Census: Standard Area Statistics (England). ESRC\/JISC Census Programme Cnsus Dissemination Unit","author":"Office for National Statistics","year":"2001"},{"key":"10.1016\/j.canep.2016.03.011_bib0165","series-title":"Stata Statistical Software: Release 12","author":"Stata-Corp","year":"2011"},{"key":"10.1016\/j.canep.2016.03.011_bib0170","series-title":"A Language and Environment for Statistical Computing [Internet]","author":"R. Core Team","year":"2013"},{"key":"10.1016\/j.canep.2016.03.011_bib0175","series-title":"Cancer Registration: Principles and Methods","first-page":"295 p.","author":"Jensen","year":"1991"},{"key":"10.1016\/j.canep.2016.03.011_bib0180","series-title":"Strel Computer Program and Life Tables for Cancer Survival Analysis [Internet]","author":"CRUK Cancer Survival Group","year":"2006"},{"issue":"April (2)","key":"10.1016\/j.canep.2016.03.011_bib0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canep.2014.02.005","article-title":"Determining disease prevalence from incidence and survival using simulation techniques","volume":"38","author":"Crouch","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2016.03.011_bib0190","doi-asserted-by":"crossref","unstructured":"Smith A., Crouch S., Lax S., Li J., Painter D., Howell D., et al. Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network. Br J Cancer [Internet]. 2015 Mar 24 [cited 2015 Mar 30]; Available from: http:\/\/www.nature.com\/bjc\/journal\/vaop\/ncurrent\/full\/bjc201594a.html.","DOI":"10.1038\/bjc.2015.94"},{"issue":"January (3)","key":"10.1016\/j.canep.2016.03.011_bib0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"October (17)","key":"10.1016\/j.canep.2016.03.011_bib0200","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","volume":"122","author":"Malcovati","year":"2013","journal-title":"Blood"},{"issue":"May (5)","key":"10.1016\/j.canep.2016.03.011_bib0205","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3324\/haematol.2011.056879","article-title":"Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors","volume":"97","author":"Parmentier","year":"2012","journal-title":"Haematologica"},{"issue":"December (4)","key":"10.1016\/j.canep.2016.03.011_bib0210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11899-012-0140-3","article-title":"Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors","volume":"7","author":"Steensma","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"December (4)","key":"10.1016\/j.canep.2016.03.011_bib0215","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11899-014-0228-z","article-title":"Epidemiology of MPN: what do we know?","volume":"9","author":"Anderson","year":"2014","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"April (4)","key":"10.1016\/j.canep.2016.03.011_bib0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ejh.12256","article-title":"Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union","volume":"92","author":"Moulard","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"May (5)","key":"10.1016\/j.canep.2016.03.011_bib0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ajh.21129","article-title":"Prevalence of polycythemia vera and essential thrombocythemia","volume":"83","author":"Ma","year":"2008","journal-title":"Am. J. Hematol."},{"issue":"July (1)","key":"10.1016\/j.canep.2016.03.011_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001\u20132004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"issue":"December (12)","key":"10.1016\/j.canep.2016.03.011_bib0235","first-page":"1596","article-title":"Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes","volume":"91","author":"Germing","year":"2006","journal-title":"Haematologica"},{"issue":"December (12)","key":"10.1016\/j.canep.2016.03.011_bib0240","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","article-title":"Incidence and prevalence of myelodysplastic syndromes: data from the D\u00fcsseldorf MDS-registry","volume":"35","author":"Neukirchen","year":"2011","journal-title":"Leuk. Res."},{"issue":"July (7)","key":"10.1016\/j.canep.2016.03.011_bib0245","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2015.55","volume":"29","author":"Della Porta","year":"2015","journal-title":"Leukemia"},{"issue":"November (17)","key":"10.1016\/j.canep.2016.03.011_bib0250","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.ejca.2012.05.024","article-title":"Incidence, survival and prevalence of myeloid malignancies in Europe","volume":"48","author":"Visser","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"June (6)","key":"10.1016\/j.canep.2016.03.011_bib0255","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/leu.2011.391","article-title":"Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study","volume":"26","author":"Germing","year":"2012","journal-title":"Leukemia"},{"issue":"February (20)","key":"10.1016\/j.canep.2016.03.011_bib0260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3324\/haematol.2012.064014","article-title":"Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study","volume":"98","author":"Maynadi\u00e9","year":"2013","journal-title":"Haematologica"},{"issue":"April (4)","key":"10.1016\/j.canep.2016.03.011_bib0265","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/10428194.2014.947610","article-title":"Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study","volume":"56","author":"Osca-Gelis","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"October (15)","key":"10.1016\/j.canep.2016.03.011_bib0270","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ejca.2015.08.003","article-title":"Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000\u20132007: Results of EUROCARE-5 population-based study","volume":"51","author":"De Angelis","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2016.03.011_bib0275","doi-asserted-by":"crossref","first-page":"e004266","DOI":"10.1136\/bmjopen-2013-004266","article-title":"Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort","volume":"4","author":"Smith","year":"2014","journal-title":"BMJ Open"},{"issue":"August (7)","key":"10.1016\/j.canep.2016.03.011_bib0280","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood-2013-04-495598","article-title":"Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry","volume":"122","author":"H\u00f6glund","year":"2013","journal-title":"Blood"},{"issue":"March (2)","key":"10.1016\/j.canep.2016.03.011_bib0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00277-015-2314-2","article-title":"Epidemiology of chronic myeloid leukaemia: an update","volume":"94","author":"H\u00f6glund","year":"2015","journal-title":"Ann. Hematol."},{"issue":"April (17)","key":"10.1016\/j.canep.2016.03.011_bib0290","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the real world: why population-based registries are needed","volume":"119","author":"Juliusson","year":"2012","journal-title":"Blood"},{"issue":"September","key":"10.1016\/j.canep.2016.03.011_bib0295","article-title":"Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma","volume":"2","author":"Smith","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"January (9760)","key":"10.1016\/j.canep.2016.03.011_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK: 1995\u20132007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data","volume":"377","author":"Coleman","year":"2011","journal-title":"Lancet"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T15:42:59Z","timestamp":1567784579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782116300364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":60,"alternative-id":["S1877782116300364"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2016.03.011","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004\u201315","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}